Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | AQST | PROC | VRCA | ||
Company | Aquestive Therapeutics Inc | Procaps Group S.A. | Verrica Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 4.00 | 2.65 | 6.62 | ||
High | 4.25 | 2.74 | 6.90 | ||
Low | 3.95 | 2.60 | 6.62 | ||
Last | 4.07 | 2.73 | 6.87 | ||
Change | +0.14 | -0.02 | +0.22 | ||
% Change | +3.56% | -0.83% | +3.31% | ||
Volume | 2,986,600 | 1,600 | 111,000 | ||
20-Day Average Volume | 2,461,850 | 3,970 | 180,335 | ||
Previous Close | 3.93 | 2.75 | 6.65 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 4.10 | 2.74 | 6.76 | ||
20-Day Raw Stochastic | 42.68% | 35.84% | 74.14% | ||
20-Day Relative Strength | 50.21% | 43.24% | 60.92% | ||
Weighted Alpha | +89.60 | -42.29 | +2.93 | ||
Today's Opinion | 48% Buy | 100% Sell | 100% Buy | ||
Previous Opinion | 56% Buy | 96% Sell | 88% Buy | ||
Last Month's Opinion | 80% Buy | 56% Sell | 80% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -0.85% since 04/19/24 | +1.76% since 04/17/24 | -1.58% since 04/19/24 | ||
Low | 3.78 on 04/25/24 | 2.60 on 04/25/24 | 6.57 on 04/22/24 | ||
High | 4.50 on 04/23/24 | 2.99 on 04/23/24 | 7.00 on 04/22/24 | ||
1-Month | |||||
%Chg | +0.25% since 03/26/24 | -9.10% since 03/25/24 | +29.14% since 03/26/24 | ||
Low | 3.72 on 04/16/24 | 2.53 on 04/09/24 | 5.28 on 03/27/24 | ||
High | 4.54 on 04/19/24 | 3.08 on 04/03/24 | 7.32 on 04/10/24 | ||
3-Month | |||||
%Chg | +70.29% since 01/26/24 | -33.65% since 01/25/24 | +18.65% since 01/26/24 | ||
Low | 2.36 on 01/29/24 | 2.53 on 04/09/24 | 4.60 on 03/20/24 | ||
High | 6.23 on 03/18/24 | 4.28 on 01/30/24 | 7.32 on 04/10/24 | ||
6-Month | |||||
%Chg | +188.65% since 10/26/23 | -3.98% since 10/25/23 | +95.73% since 10/26/23 | ||
Low | 1.38 on 10/27/23 | 2.33 on 11/15/23 | 2.86 on 11/14/23 | ||
High | 6.23 on 03/18/24 | 4.95 on 01/11/24 | 7.51 on 12/27/23 | ||
Key Statistics | |||||
Market Capitalization, $K | 298,335 | 307,671 | 291,425 | ||
Shares Outstanding, K | 73,301 | 112,820 | 42,420 | ||
Annual Sales | 50,580,000 | 409,920,000 | 5,120,000 | ||
Annual Net Income | -7,870,000 | 42,540,000 | -67,000,000 | ||
Last Quarter Sales | 13,210,000 | 118,410,000 | 1,990,000 | ||
Last Quarter Net Income | -8,110,000 | 8,190,000 | -24,610,000 | ||
60-Month Beta | 2.87 | 0.13 | 1.88 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.12 on 03/05/24 | 0.08 on 12/26/23 | -0.48 on 02/29/24 | ||
Latest Earnings Date | 05/07/24 | 06/03/24 | 05/14/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 5.29 | 0.00 |